The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
Clinical trial NCT06635421 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06635421
- Sponsor
- MetroHealth Medical Center
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-01
- Primary completion
- 2026-12-31
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.